Estrogen receptor-mediated down-regulation of corticotropin-releasing hormone gene expression is dependent on a cyclic adenosine 3',5'-monophosphate regulatory element in human placental syncytiotrophoblast cells.
Placental CRH plays a major role in the mechanisms controlling human pregnancy and parturition. Understanding how placental CRH production is regulated is therefore of importance. Previously we have shown that placental expression of CRH peptide and mRNA are inhibited by estrogens, in contrast to the stimulatory effects of estrogen on hypothalamic CRH production. Our current study found that in placental cells cotransfected with a CRH promoter construct and an estrogen receptor-alpha expression vector results in a differential regulation whereby 17beta-estradiol (E2) decreased and the putative pure estrogen antagonist, ICI 182780, increased CRH promoter activity. Sequential deletion of the CRH promoter indicated that the region between -248 and -213 bp was essential for the effect of both E2 and ICI 182780. This region contains a consensus cAMP regulatory element (CRE) that is a requirement for E2- and ICI 182780-mediated activity because the CRE motif can confer E2 inhibition on a heterologous promoter such as rabbit beta-globin. Mutation of the CRE resulted in a complete reversal of E2 and ICI 182780 regulatory effects. In summary, our results demonstrate that a consensus CRE is required for the action of estrogen receptor ligands in human placental syncytiotrophoblast cells.
Ni
Xin
X
Department of Physiology, Second Military Medical University, Shanghai 200433, People's Republic of China.
Hou
Yue
Y
King
Bruce R
BR
Tang
Xiaolu
X
Read
Mark A
MA
Smith
Roger
R
Nicholson
Richard C
RC
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D002478:Cells, Cultured / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000235:genetics*; D017362:Cyclic AMP Response Element-Binding Protein / Q000502:physiology*; D015536:Down-Regulation / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens / Q000502:physiology; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D008024:Ligands; D010920:Placenta / Q000166:cytology / Q000378:metabolism*; D011247:Pregnancy; D011401:Promoter Regions, Genetic / Q000187:drug effects; D011960:Receptors, Estrogen / Q000378:metabolism / Q000502:physiology*; D020218:Response Elements / Q000235:genetics; D014327:Trophoblasts / Q000378:metabolism*
D017362:Cyclic AMP Response Element-Binding Protein; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens; D008024:Ligands; D011960:Receptors, Estrogen; D015124:8-Bromo Cyclic Adenosine Monophosphate; D004958:Estradiol; D003346:Corticotropin-Releasing Hormone